During the past decade, Urology Center Of Florida conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Urology Center Of Florida" #1 collaborator was "Data & Inference, Inc." with 1 trials as a collaborator and "Novella Clinical" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Urology Center Of Florida" are "Overactive Bladder" (3 trials), "Hypogonadism" (1 trials) and "Irritable Bowel Syndrome Characterized by Constipation" (1 trials). Many other conditions were trialed in "Urology Center Of Florida" in a lesser frequency.

Most popular intervention types in "Urology Center Of Florida" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Vibegron" (2 trials), "(VERV™ System)" (1 trials), "Natesto" (1 trials) and "Plecanatide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urology Center Of Florida" are 3 trials for "Male" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Urology Center Of Florida". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Urology Center Of Florida, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Urology Center Of Florida, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".